Maria G. Beconi

Maria G. Beconi is a pharmaceutical executive with over 20 years of experience in research and development.1 She is currently serving as the Co-Founder, Founder CEO, and Scientific Advisor at a new company in the Atlas Venture portfolio.34

Professional Background

Throughout her career, Beconi has focused on making a difference in the pharmaceutical industry, particularly in R&D.1 Her extensive experience includes:

• Working with start-up companies and established pharmaceutical organizations
• Involvement in clinical trials and drug development processes2
• Contributing to the advancement of therapeutic solutions

Recent Positions

Before her current role, Beconi held several notable positions:

• Chief Science Officer at ZielBio: She was appointed to this role in January 20226
• Association with Disc Medicine: In July 2021, she was involved with Disc Medicine as they initiated their first-in-human Phase 1 clinical study2

Education and Expertise

Maria G. Beconi received her education from Michigan State University.1 Her expertise likely spans various areas of pharmaceutical research and development, given her extensive experience in the field.

Inventions and Patents

Beconi has been involved in innovation within the pharmaceutical industry, as evidenced by her patent applications and granted patents for various inventions.5

Maria G. Beconi's LinkedIn profile (username: maria-beconi) would likely provide more detailed information about her professional journey, accomplishments, and current endeavors in the pharmaceutical and biotechnology sectors.